Adjuvant chemoimmunotherapy stage I/II malignant melanoma.

Knost, J A; Reynolds, V; Greco, F A; Oldham, R K

Knost, J A; Reynolds, V; Greco, F A; Oldham, R K.

J Surg Oncol ; 19(3): 165-70, 1982 Mar.

Article in En | MEDLINE | ID: mdl-7040820

Subject(s)

BCG Vaccine/therapeutic use; Dacarbazine/therapeutic use; Melanoma/therapy; Nitrosourea Compounds/therapeutic use; Semustine/therapeutic use; Skin Neoplasms/therapy; Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Humans; Lymph Node Excision; Male; Melanoma/drug therapy; Middle Aged; Prospective Studies; Random Allocation; Skin Neoplasms/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Semustine / Skin Neoplasms / BCG Vaccine / Dacarbazine / Melanoma / Nitrosourea Compounds Type of study: Clinical_trials / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Surg Oncol Year: 1982 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links